Management of Abdominal Abscess or Hematoma
For abdominal abscesses, percutaneous catheter drainage (PCD) combined with antibiotics is the first-line treatment, while hematomas typically require conservative management unless infected or causing complications. 1
Diagnostic Approach
Initial Imaging Selection
- CT with IV contrast is the preferred initial imaging modality for adults with suspected abdominal abscess or hematoma, providing superior sensitivity (100% in available studies), ability to localize collections, and assessment of surrounding structures 1
- CT maintains accuracy despite surgical dressings, stomas, drains, and is less operator-dependent than ultrasound 1
- Ultrasound is appropriate for children to avoid radiation exposure, though CT or MRI should follow if US is negative but clinical suspicion persists 1
- Noncontrast CT can rapidly confirm or exclude bleeding in hematomas and is useful when renal function is compromised 1
Distinguishing Abscess from Hematoma
- Abscesses appear as thin-walled fluid collections with surrounding inflammation, often with gas or debris 1
- Hematomas show high attenuation on noncontrast CT when acute, mixed attenuation with rebleeding, and low attenuation when subacute to chronic 1
- Needle aspiration can definitively distinguish between infected fluid (abscess) and blood products (hematoma) when imaging is equivocal 1, 2
Management of Abdominal Abscess
Size-Based Treatment Algorithm
Small abscesses (<3 cm):
- Trial of antibiotics alone for 7 days in immunocompetent patients 1
- Consider needle aspiration if persistent, to guide antibiotic coverage 1
- Follow-up imaging and repeat aspiration if collection does not resolve 1
Large abscesses (≥3 cm):
- Percutaneous catheter drainage (PCD) combined with antibiotics is the primary treatment 1
- PCD achieves 70-90% efficacy for mature abscesses and significantly reduces hospital stays compared to surgery 1
- Antibiotic duration: 4 days in immunocompetent, non-critically ill patients with adequate source control 1
- Extend antibiotics to 7 days in immunocompromised or critically ill patients based on clinical response and inflammatory markers 1
Antibiotic Selection
For immunocompetent patients with adequate source control:
- Piperacillin/tazobactam 4 g/0.5 g q6h or 16 g/2 g continuous infusion 1
- Alternative: Eravacycline 1 mg/kg q12h 1
For inadequate/delayed source control or high risk of ESBL-producing organisms:
For septic shock:
- Meropenem 1 g q6h by extended infusion or continuous infusion 1
- Alternatives: Doripenem 500 mg q8h, Imipenem/cilastatin 500 mg q6h by extended infusion 1
Management of Failed PCD
When drainage is inadequate after 2 weeks despite catheter in place:
- Catheter upsizing or manipulation - achieves clinical success without surgery in 76.8% of refractory cases 1
- Intracavitary thrombolytic therapy with alteplase for complex, multiseptated collections - 72% clinical success rate versus 22% with saline alone 1
- Laparoscopic drainage for direct visualization and exploration 1
- Open surgical drainage if underlying process requires surgical management (bowel perforation, fistula) 1
Specific Clinical Scenarios
Crohn's disease-associated abscesses:
- Initial PCD combined with antibiotics, high-dose steroids, bowel rest, and hyperalimentation 1
- PCD performed 37 days before surgery significantly reduces postoperative septic complications 1
- 33-50% ultimately require surgical drainage or resection despite initial PCD success 1
- Optimal timing for elective surgery is 2-4 weeks after successful PCD to minimize complications and stoma formation 1
Diverticular abscesses:
- PCD with antibiotics obviates need for subsequent colectomy in 85% of cases 1
- Small diverticular abscesses: antibiotics alone for 7 days 1
- Large diverticular abscesses: PCD combined with antibiotics for 4 days 1
Post-appendicitis abscesses:
- PCD with antibiotics as initial management reduces complications and hospital stay versus immediate surgery 1
- 80% of patients are cured without subsequent interval appendectomy 1
Management of Abdominal Hematoma
Conservative Management
- Most hematomas are managed conservatively with observation and serial imaging unless complications develop 1, 3
- Monitor for signs of infection, expansion, or hemodynamic instability 1
- Serial CT imaging to assess for rebleeding (mixed attenuation) or abscess formation 1
Indications for Intervention
Active bleeding:
- CT angiography (CTA) detects bleeding rates as low as 0.3 mL/min with sensitivity of 59.5% for active extravasation 1
- Angiography with transcatheter arterial embolization (TAE) for hemodynamically unstable patients or confirmed active arterial bleeding 1
- TAE achieves cessation of bleeding in all cases when bleeding vessel is identified 1
Infected hematoma (evolving to abscess):
- PCD is curative in only 0% of infected organized hematomas or thick phlegmons - these typically require surgical drainage 2
- Diagnosis confirmed by aspiration showing purulent material with positive cultures 3, 4
- Treatment includes antibiotics plus either PCD or surgical evacuation depending on complexity 3
Specific Hematoma Locations
Psoas muscle hematoma:
- Conservative management unless infected 3
- If abscess develops: ultrasound-guided drainage plus antibiotics 3
- Surgical evacuation if drainage fails or at time of laparotomy for associated injuries 3
Retroperitoneal hematoma:
- Noncontrast CT confirms diagnosis and assesses acuity based on attenuation 1
- CTA if active bleeding suspected to guide potential TAE 1
- Urgent angiography reserved for hemodynamically unstable patients with high suspicion 1
Critical Pitfalls to Avoid
- Never remove drainage catheter with continued antibiotics alone for persistent collection - this is inappropriate management 1
- Drain removal criteria: resolution of infection signs, catheter output <10-20 cc/day, and imaging confirmation of abscess resolution 1
- Do not assume all fluid collections are abscesses - needle aspiration distinguishes sterile hematomas, seromas, and lymphoceles from infected collections 1, 2
- PCD failure is common with fungal infections (0% cure rate), enteric fistulas (28% cure rate), and infected necrotic tumors (0% cure rate) - maintain low threshold for surgery 2
- Patients with ongoing signs of infection beyond 7 days of treatment warrant diagnostic investigation for complications 1